Geode Capital Management, LLC Night Hawk Biosciences, Inc. Call Options Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NHWK
# of Institutions
5Shares Held
48.5KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X028.8KShares$4,6070.0% of portfolio
-
Goldman Sachs Group Inc New York, NY14.4KShares$2,3030.0% of portfolio
-
Cutler Group LP5KShares$8000.0% of portfolio
-
Huntington National Bank Columbus, OH220Shares$350.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ100Shares$160.0% of portfolio
About NightHawk Biosciences, Inc.
- Ticker NHWK
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,661,500
- Market Cap $4.11M
- Description
- NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...